5.1 EPOXYEICOSATRIENOIC ACIDS IN THE REGULATION OF VASCULAR TONE

5.1 EPOXYEICOSATRIENOIC ACIDS IN THE REGULATION OF VASCULAR TONE

Bibliographic Details
Main Authors:	L. Yang, J. Cheriyan, C. McEniery, I. Wilkinson
Format:	Article
Language:	English
Published:	BMC 2014-11-01
Series:	Artery Research
Online Access:	https://www.atlantis-press.com/article/125929084/view

Similar Items

Epoxyeicosatrienoic Acid and Prostanoid Crosstalk at the Receptor and Intracellular Signaling Levels to Maintain Vascular Tone
by: Pedro Felipe Malacarne, et al.
Published: (2022-05-01)

The Role of Epoxyeicosatrienoic Acids in Cardiac Remodeling
by: Jinsheng Lai, et al.
Published: (2021-02-01)

The Metabolism of Epoxyeicosatrienoic Acids by Soluble Epoxide Hydrolase Is Protective against the Development of Vascular Calcification
by: Olivier Varennes, et al.
Published: (2020-06-01)

Aging, estrogen loss and epoxyeicosatrienoic acids (EETs).
by: Alison R Lee, et al.
Published: (2013-01-01)

Arachidonate epoxygenase: identification of epoxyeicosatrienoic acids in rabbit kidney.
by: J R Falck, et al.
Published: (1987-07-01)

14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells.
by: M VanRollins, et al.
Published: (1993-11-01)

Epoxyeicosatrienoic Acids and/or Their Metabolites Promote Hypoxic Response of Cells
by: Sachiko Suzuki, et al.
Published: (2008-01-01)

Epoxyeicosatrienoic Acids and Fibrosis: Recent Insights for the Novel Therapeutic Strategies
by: Xin-Xin Guan, et al.
Published: (2021-10-01)

Development of epoxyeicosatrienoic acid analogs with in vivo anti-hypertensive actions
by: John D Imig, et al.
Published: (2010-12-01)

12.6 THE ROLE OF NEURONAL NITRIC OXIDE SYNTHASE IN YOUNG ADULTS
by: Jessica Middlemiss, et al.
Published: (2016-11-01)

5.1 MILD REDUCTION OF GLOMERULAR FILTRATION RATE IS ASSOCIATED WITH INCREASED SYSTEMIC VASCULAR RESISTANCE INDEPENDENT OF CHANGES IN CARDIAC AUTONOMIC TONE
by: Ilkka Porsti, et al.
Published: (2016-11-01)

P1.08 THE BRACHIO-TO-RADIAL PULSE PRESSURE AMPLIFICATION AND ITS CONTRIBUTION TO CENTRAL-TO-PERIPHERAL PULSE PRESSURE AMPLIFICATION
by: G. Pucci, et al.
Published: (2010-12-01)

P7.14 SERUM INFLAMMATORY MARKERS ARE POOR PREDICTORS OF VASCULAR INFLAMMATION AND VASCULAR INFLAMMATION DOES NOT DETERMINE AORTIC STIFFNESS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
by: Marie Fisk*, et al.
Published: (2015-11-01)

P.066 PERIPHERAL VASCULAR DISEASE IS ASSOCIATED WITH INCREASED AORTIC STIFFNESS
by: S.M.L. Wallace, et al.
Published: (2007-08-01)

11,12 Epoxyeicosatrienoic Acid Rescues Deteriorated Wound Healing in Diabetes
by: Katharina Sommer, et al.
Published: (2021-10-01)

EPOXYEICOSATRIENOIC ACID ANALOG ATTENUATES ANGIOTENSIN II HYPERTENSION AND KIDNEY INJURY
by: Md. Abdul Hye Khan, et al.
Published: (2014-09-01)

Plasma epoxyeicosatrienoic acids and diabetes-related cardiovascular disease: The cardiovascular health study
by: Rozenn N. Lemaitre, et al.
Published: (2022-09-01)

Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition
by: Melissa Skibba, et al.
Published: (2017-06-01)

P5.14 IMPACT OF KIDNEY DONATION ON AORTIC STIFFNESS: A FEASIBILITY STUDY
by: J. Smith, et al.
Published: (2014-11-01)

Conversion of epoxyeicosatrienoic acids (EETs) to chain-shortened epoxy fatty acids by human skin fibroblasts
by: Xiang Fang, et al.
Published: (2000-01-01)

Simvastatin prevents acute inflammation-induced aortic stiffening and endothelial dysfunction in healthy volunteers
by: Wallace, S, et al.
Published: (2007)

02.01 SIMVASTATIN PREVENTS ACUTE INFLAMMATION-INDUCED AORTIC STIFFENING IN HEALTHY VOLUNTEERS.
by: S. Wallace*, et al.
Published: (2007-06-01)

Fatty acid binding proteins are novel modulators of synaptic epoxyeicosatrienoic acid signaling in the brain
by: Sherrye T. Glaser, et al.
Published: (2023-09-01)

Plasma epoxyeicosatrienoic acids and dihydroxyeicosatrieonic acids, insulin, glucose and risk of diabetes: The strong heart study
by: Rozenn N. Lemaitre, et al.
Published: (2021-04-01)

Erratum on: Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury
by: Frontiers eProduction Office
Published: (2014-11-01)

The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids
by: Shan Jiang, et al.
Published: (2024-04-01)

CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators
by: Zeqi Shi, et al.
Published: (2022-06-01)

Epoxyeicosatrienoic acid activation moderates endothelial mesenchymal transition to reduce obstructive nephropathy
by: Babu J. Padanilam
Published: (2017-12-01)

8,9-Epoxyeicosatrienoic acid inhibits antibody production of B lymphocytes in mice.
by: Yanxiang Gao, et al.
Published: (2012-01-01)

CYP2C19 variants and epoxyeicosatrienoic acids in patients with microvascular angina
by: Tomonori Akasaka, et al.
Published: (2017-06-01)

Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice
by: Md. Abdul Hye Khan, et al.
Published: (2019-05-01)

Competitive bidirectional pathways of vascular tone regulation via arachidonic acid metabolites
by: Verveyko, Darya V., et al.
Published: (2023-06-01)

Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation.
by: Booth, A, et al.
Published: (2004)

Infliximab improves endothelial dysfunction in systemic vasculitis: A model of vascular inflammation
by: Booth, A, et al.
Published: (2004)

5.4 Acute Effects of Indapamide Treatment on Haemodynamics and Glycosaminoglycan-Mediated Non-Osmotic Skin Sodium Storage in Healthy Humans
by: Kathleen Connolly, et al.
Published: (2020-02-01)

P10.9 INTERACTION BETWEEN STROKE VOLUME AND PERIPHERAL VASCULAR RESISTANCE IN DEFINING SYSTOLIC BLOOD PRESSURE IN YOUNG ADULTS
by: A. Cocks, et al.
Published: (2014-11-01)

Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary disease
by: Marie Fisk, et al.
Published: (2018-05-01)

P6.10 A COMPARISON BETWEEN THE VICORDER AND SPHYGMOCOR DEVICES FOR THE NON-INVASIVE ASSESSMENT OF CENTRAL BLOOD PRESSURE
by: G. Pucci, et al.
Published: (2009-12-01)

Infliximab improves endothelial dysfunction in systemic vasculitis: A model of vascular inflammation
by: Booth, A, et al.
Published: (2004)

Eicosanoids in human heart failure: pilot study of plasma epoxyeicosatrienoic and dihydroxyeicosatrienoic acid levels
by: Petr Kala, et al.
Published: (2023-02-01)